Hi all,Imagion is pleased to share that our MagSense Phase I...

Hi all,

Imagion is pleased to share that our MagSense Phase I study for staging HER2 breast cancer has been posted to the Australia New Zealand Clinical Trials Registry (ANZCTR). If you are interested in details of the study plan, it is available here: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380834&isReview=true

We note that registry shows the study as “Not yet recruiting” which reflected the study status at the time of submission to the registry. As we have previously announced, the study is open for enrolment at Monash Health. We expect that throughout the study, there may be an administrative lag in keeping the registry up-to-date as the study progresses.

It is also important to note that the anticipated first patient enrolment date shown on the registry was an estimate at the time of submission to the registry and could differ from the actual date. We look forward to keeping the markets informed of progress with the study.